CDEK
← All organizations

Noven Therapeutics

For profit

Also known as: NOVEN | Noven Pharmaceuticals, Inc. | NOVEN PHARMS INC | NOVEN THERAP | Noven Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Aug 1, 2004

First marketed drug

Jul 1, 1987

Last known activity

Jun 3, 2021

Acquired by Hisamitsu Pharmaceutical Co., Inc. on Jul 14, 2009

Timeline

1980s

  1. Jul 1, 1987

    Noven Therapeutics— Founded

1990s

  1. Aug 7, 1998

    estradiol— Marketing Organization

  2. Aug 7, 1998

    norethindrone— NDA Secondary Org

2000s

  1. Aug 15, 2007

    JDS Pharmaceuticals— Acquired

  2. Jul 14, 2009

    Hisamitsu Pharmaceutical Co., Inc.— Acquired By

Drugs by trial phase (8 distinct, 20 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (3 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (8)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (27)

Details

Founded
Miami, FL, US Jul 1, 1987
Last known activity
Jun 3, 2021

Notes

Acquired by Hisamitsu in 14 Jul 2009